Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7Stomach Neoplasms 4Rectal Neoplasms 4Neoplasm Metastasis 2Colonic Neoplasms 2Turcot syndrome 1Recurrence 1Neoplasms 1Locally Advanced Rectal Cancer (LARC) 1Locally Advanced Colorectal Cancer 1Gastrointestinal Neoplasms 1Gastric Cancer Stage 1Adenocarcinoma of the Lower Rectum 1

Interventions

dostarlimab 2sintilimab 1XELOX 1Radiotherapy 1Oxaliplatin 1Neoadjuvant Therapy 1Immune Checkpoint Inhibitors 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Rectal Cancer (LARC) × XELOX × 1 year × Clear all
NCT07381777 2026-02-02

IMMUNOSTAR

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Not yet recruiting
270 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡